The Toxic Effects of Lithium Combined with Quetiapine and Risperidoneon Organ Systems
Journal Title: Turkish Journal of Intensive Care - Year 2020, Vol 18, Issue 2
Abstract
Lithium, first approved by the American Food and Drug Administration (FDA) for mania treatment in 1970, is used as the gold standard in the treatment of bipolar disorder in these days. Its neuroprotective effects, its usefulness in preventing recurrences, its property to reduce suicidal acts and thoughts have led it to be preferred against this disease.Though risperidone, one of the antipsychotic drugs, in 1994 while quetiapine in 1997 received FDA approval for the treatment of schizophrenia, these have used for the bipolar disorder treatment in recent years. Studies have shown that response and remission rates are better in combination therapies than in monotherapy for bipolar disorder. Combination therapies are applied to cases that are considered to be resistant to treatment, to the patients who give partial response, or to those who do not respond to the initial treatment. However, the main disadvantage of these treatments is that they increase the side effects. It is known that the combination of lithium with antipsychotic, antidepressant and anticonvulsant drugs is a predisposing risk factor for high lithium levels. The narrow therapeutic index of lithium also poses a potential risk of toxicity. Therefore, neurotoxic, nephrotoxic and cardiotoxic side effects of lithium on organ systems may occur. Despite these frequently preferred combination therapies, the number of case reports of severe intoxication associated with them is scarce. In this study, we aimed to discuss the effect of severe toxicity due to triple combination therapy on organ systems.
Authors and Affiliations
Canan Salman Önemli, Özlem Sarıtabak
Keywords
Related Articles
- EP ID EP685395
- DOI 10.4274/tybd.galenos.2019.19970
- Views 115
- Downloads 0
A Lethal Outcome After Overdose of Rivastigmine Transdermal Patch in an Elderly Patient
Rivastigmine is a cholinesterase inhibitor with oral or transdermal forms used in the treatment of dementia. In this study, the case of a 92-year-old male with Alzheimer’s type dementia was presented with rivastigmine to...
The Parameters Affecting the Outcome in Drowning Cases in Intensive Care Unit: Eight Years of Retrospective Patient Data
Objective: Drowning is a common and important cause of accidental deaths. Complications and mortality rates are high in patients requiring intensive care unit (ICU) support. The aim of our study was to determine the clin...
Are the Tidal Volumes Used in Intensive Care Units Suitable for Lung Protective Ventilation? Can Training Ensure Compatibility?
Objective: Low tidal volume (VT) and lung protective ventilation (LPV) are recommended to prevent lung injury associated with invasive mechanical ventilation (IMV). Present study aimed to determine the patients with risk...
Evaluation of Organ Donation Rates Among in Patients with Anticipated Imminent Brain Death
Objective: The aim of this study was to investigate the progression of brain death in close follow-up of comatose patients in intensive care unit (ICU), to reveal the data on epidemiological and clinical characteristics...
Mushroom That Break Hearts: A Case Report
Because of the high mortality and morbidity, mushroom poisoning is a significant medical emergency that causes liver and kidney damage; however, its effect on cardiac functions has not been established yet. We aimed to p...